APAC IPOs & Placements, Aequitas Research

Clarence Chu

APAC IPOs & Placements

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

Jinmao Property Services / Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/jinmao-property-services" target="_blank" data-smartkarma-citation="entities:34170:1" rel="noopener">Jinmao Property Services (JM HK)</a> is looking to raise around US$105m in its Hong Kong IPO.</li>
<li>At listing, it is asking for a steep premium and 82% of the deal size has already been taken up by cornerstones, not leaving a whole lot for other investors.</li>
<li>In this note, we will look at deal dynamics, assumptions, and share our thoughts on valuation.</li>
</ul>



Jinmao Property Services (JM HK) is looking to raise around US$105m in its Hong Kong IPO.
At listing, it is asking for a steep premium and 82% of the deal size has already been taken up by cornerstones, not leaving a whole lot for other investors.
In this note, we will look at deal dynamics, assumptions, and share our thoughts on valuation.


Jinmao Property Services IPO - Premium Asking Valuation and Cornerstones Took up 80% of Deal

<ul>
<li>
<a href="https://www.smartkarma.com/entities/yunkang-group" target="_blank" data-smartkarma-citation="entities:35631:1" rel="noopener">Yunkang Group (YK HK)</a> is looking to raise about US$200m in its upcoming Hong Kong IPO. </li>
<li>Yunkang Group is a medical operation service provider in China and as per F&amp;S, had a market share of 3.7% in China’s medical operation service market as per 2020 revenue.</li>
<li>While it has managed to grow its on-site diagnostics centers, the firm has to prove that it can still thrive post-COVID.</li>
</ul>



Yunkang Group (YK HK) is looking to raise about US$200m in its upcoming Hong Kong IPO. 
Yunkang Group is a medical operation service provider in China and as per F&amp;S, had a market share of 3.7% in China’s medical operation service market as per 2020 revenue.
While it has managed to grow its on-site diagnostics centers, the firm has to prove that it can still thrive post-COVID.


Yunkang Group Pre-IPO - Would Need to Prove Itself Post-COVID

China and US Equity Analyst

Roger Xie

Equity Bottom-Up

<ul>
<li>The sluggish share performance of <a href="https://www.smartkarma.com/entities/hong-kong-exchanges-clearing" target="_blank" data-smartkarma-citation="entities:490:1" rel="noopener">HKEX (388 HK)</a> underscored the weak trading activities at Hong Kong, its January average daily turnover (ADT) is down 47% year-over-year.</li>
<li>Hong Kong's surging COVID cases have already accounted for more confirmed infections than all previous outbreak combined, we believe this will also dampen market sentiment short-term.</li>
<li>However, we remain bullish on HKEX (388 HK) with the view that China economy will likely rebound in 2022, which will drive the rebound of IPO activities and trading volume. </li>
</ul>


The sluggish share performance of HKEX (388 HK) underscored the weak trading activities at Hong Kong, its January average daily turnover (ADT) is down 47% year-over-year.
Hong Kong's surging COVID cases have already accounted for more confirmed infections than all previous outbreak combined, we believe this will also dampen market sentiment short-term.
However, we remain bullish on HKEX (388 HK) with the view that China economy will likely rebound in 2022, which will drive the rebound of IPO activities and trading volume. 


HKEx (388.HK): Latest COVID Outbreak Weighted Trading Activities

<ul>
<li>
<a href="https://www.smartkarma.com/entities/huitongda" target="_blank" data-smartkarma-citation="entities:33789:1" rel="noopener">Huitongda (9878 HK)</a> raised around US$285m in its Hong Kong IPO.</li>
<li>Overall, we are not comfortable with paying a premium valuation for HTD given its small scale of operations in a highly competitive and fragmented market. </li>
<li>In this note, we will look at the trading dynamics and current valuation.</li>
</ul>



Huitongda (9878 HK) raised around US$285m in its Hong Kong IPO.
Overall, we are not comfortable with paying a premium valuation for HTD given its small scale of operations in a highly competitive and fragmented market. 
In this note, we will look at the trading dynamics and current valuation.


Huitongda (汇通达) IPO Trading - Subscription Rates and Cornerstone Quality Leaves Much to Be Desired

<ul>
<li>
<a href="https://www.smartkarma.com/entities/linmon-media" target="_blank" data-smartkarma-citation="entities:34550:1" rel="noopener">Linmon Media (LM HK)</a> is looking to raise about US$300m in its upcoming Hong Kong IPO.</li>
<li>Linmon Media (LM) is a content production firm that operates the full value chain of investment, production, distribution, promotion and derivatives licensing of drama series.</li>
<li>In this note, we take a look at LM’s business, financials, and share our thoughts on the IPO.</li>
</ul>



Linmon Media (LM HK) is looking to raise about US$300m in its upcoming Hong Kong IPO.
Linmon Media (LM) is a content production firm that operates the full value chain of investment, production, distribution, promotion and derivatives licensing of drama series.
In this note, we take a look at LM’s business, financials, and share our thoughts on the IPO.


Linmon Media (柠萌影业) Pre-IPO - Consistently Putting up a Good Show

China

Qingdao AInnovation Technology Group is an AI solutions provider offering full-stack AI-based products and solutions. According to Frost & Sullivan (F&S), the firm was the third largest AI technology driven solution provider in the enterprise AI solutions market in China in terms of 2020 revenue.

Qingdao Ainnovation Technology Group (2121 HK)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Qingdao Ainnovation Technology Group (2121 HK)

Jinmao Property Services IPO - Premium Asking Valuation and Cornerstones Took up 80% of Deal

Jinmao Property Services (JM HK) is looking to raise around US$105m in its Hong Kong IPO. In this note, we will look at deal dynamics, assumptions,...

Clarence Chu

Yunkang Group Pre-IPO - Would Need to Prove Itself Post-COVID

Yunkang Group (YK HK) is looking to raise about US$200m in its upcoming Hong Kong IPO. While it has managed to grow its on-site centers, it has to...

Clarence Chu

HKEx (388.HK): Latest COVID Outbreak Weighted Trading Activities

We remain bullish on HKEX (388 HK) with the view that China economy will likely rebound in 2022, which will drive the rebound of IPO activities and...

Roger Xie

Huitongda (汇通达) IPO Trading - Subscription Rates and Cornerstone Quality Leaves Much to Be Desired

Huitongda Network raised around US$285m in its Hong Kong IPO. In this note, we will look at the trading dynamics and current valuation.

Clarence Chu

Linmon Media (柠萌影业) Pre-IPO - Consistently Putting up a Good Show

Linmon Media (LM HK) is looking to raise about US$300m in its upcoming Hong Kong IPO. In this note, we take a look at LM’s business, financials,...

Clarence Chu

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)